Human cloning is the creation of a genetically related cell line, tissue, embryo, or potential individual using human DNA. Plus, in public discussion, the phrase usually refers to somatic cell nuclear transfer (SCNT), but it can also describe research intended to produce patient-matched stem cells. Understanding how cloning works for humans requires separating scientific possibility from science fiction, because copying nuclear DNA does not create an identical personality, memory, appearance, or life story.
What “Human Cloning” Means
Human cloning has several distinct meanings:
- Reproductive cloning: Creating an embryo with the aim of implanting it in a uterus and producing a cloned baby.
- Therapeutic cloning: Creating an early embryo for research or for deriving embryonic stem cells that are genetically similar to a patient. The embryo is not intended to develop into a person.
- Embryo splitting: Dividing an early embryo so that its parts may develop into genetically similar embryos. This resembles the natural process that produces identical twins.
- Gene cloning: Copying a particular DNA sequence in a laboratory. This is common in biomedical research but does not clone a whole person.
- Induced pluripotent stem cells (iPSCs): Reprogramming adult cells into an embryo-like stem-cell state. iPSCs can be patient-matched, but they are not cloned human beings.
When people ask how human cloning works, they are most often asking about reproductive cloning through SCNT.
How Somatic Cell Nuclear Transfer Works
SCNT replaces the nucleus of an egg cell with the nucleus from an ordinary body cell. The basic scientific sequence is:
-
A somatic cell is selected.
A somatic cell is any body cell other than a sperm or egg, such as a skin or connective-tissue cell. Its nucleus contains nearly all of the donor’s nuclear DNA. -
The nucleus is removed from an egg cell.
The egg’s own nuclear genetic material is removed while the rest of the egg, including its cytoplasm, is retained The details matter here.. -
The donor nucleus is transferred into the egg.
The egg now contains the nuclear DNA of the somatic-cell donor rather than its original nucleus. -
The egg is stimulated to begin development.
Signals from the egg’s cytoplasm initiate cell division and begin reprogramming the adult nucleus Simple as that.. -
The resulting embryo continues dividing.
If development proceeds normally, the cells can reach an early stage called a blastocyst But it adds up.. -
The embryo is used for research or implantation.
In therapeutic cloning, researchers may derive stem cells from
the blastocyst’s inner cell mass. On top of that, these stem cells can then be directed to differentiate into specific tissues—neurons, cardiomyocytes, pancreatic islet cells—for disease modeling, drug screening, or, theoretically, transplantation therapies that would avoid immune rejection. In reproductive cloning, the blastocyst would be transferred to a uterus with the intention of establishing a pregnancy Less friction, more output..
The Biological Hurdles: Why It Has Not Worked in Humans
Although SCNT has produced live offspring in more than twenty mammalian species—including sheep, mice, cattle, pigs, and, most recently, non-human primates—human reproductive cloning remains scientifically unachieved. The barriers are not merely technical; they are fundamental to human developmental biology Small thing, real impact..
Epigenetic reprogramming errors. The cytoplasm of the oocyte must erase the epigenetic marks (DNA methylation, histone modifications) that define a somatic cell’s identity and re-establish the totipotent program of an early embryo. In humans, this reprogramming is exceptionally inefficient. The donor nucleus often retains a "memory" of its differentiated state, leading to aberrant gene expression, developmental arrest, or placental abnormalities And that's really what it comes down to..
Mitochondrial heterogeneity. SCNT does not replace the egg’s mitochondria. The resulting embryo carries mitochondrial DNA (mtDNA) from the egg donor and nuclear DNA from the somatic donor. In some species, this mixing causes metabolic incompatibilities or oxidative stress that impairs development.
Spindle and chromosome instability. Human oocytes are notoriously sensitive to manipulation. Enucleation and nuclear injection can damage the meiotic spindle or centrosomal components, resulting in aneuploidy (abnormal chromosome numbers) that is lethal to the embryo.
Low efficiency and high cost. Even in optimized animal systems, live birth rates from SCNT embryos transferred to surrogates are typically 1–5 %. Applied to humans, this would require hundreds of oocytes and dozens of surrogate pregnancies for a single live birth—posing immense physical risks to women and ethical objections to the wastage of human embryos.
The Primate Precedent
The 2018 birth of two long-tailed macaques (Macaca fascicularis), Zhong Zhong and Hua Hua, via SCNT proved that the primate epigenetic barrier can be overcome. Practically speaking, researchers used fetal fibroblasts rather than adult cells and added epigenetic modulators (histone deacetylase inhibitors and Kdm4d mRNA) to improve reprogramming. Yet the efficiency remained low: 109 embryos transferred into 21 surrogates yielded six pregnancies and two live births. No human SCNT embryo has yet developed past the blastocyst stage in a reproducible, verifiable manner, and no credible scientific group has reported a human pregnancy from SCNT.
Legal and Ethical Landscape
The scientific consensus against human reproductive cloning is mirrored by a near-universal policy consensus.
- International instruments: The UNESCO Universal Declaration on the Human Genome and Human Rights (1997) and the UN Declaration on Human Cloning (2005) call for a ban on reproductive cloning as contrary to human dignity.
- National laws: Over 70 countries, including the United Kingdom, Canada, Australia, and most of the European Union, explicitly criminalize reproductive cloning. In the United States, no federal law bans it outright, but the FDA asserts regulatory authority over any human cloning attempt, effectively blocking it, and 15 states have enacted their own bans.
- Therapeutic cloning regulation: Jurisdictions diverge. The UK permits SCNT for research under strict licensing by the Human Fertilisation and Embryology Authority (HFEA). Several US states fund embryonic stem cell research including SCNT, while others prohibit embryo creation for research.
The Role of iPSCs: A Scientific Pivot
The 2006 discovery of induced pluripotent stem cells (iPSCs) by Shinya Yamanaka fundamentally altered the rationale for therapeutic cloning. iPSCs offer patient-matched pluripotent cells without creating or destroying embryos and without requiring oocytes. Worth adding: while SCNT-derived embryonic stem cells (ntESCs) may retain fewer epigenetic abnormalities and mitochondrial mutations than some iPSC lines, the logistical and ethical advantages of iPSCs have made them the dominant platform for disease modeling and regenerative medicine. Clinical trials now underway for macular degeneration, Parkinson’s disease, and spinal cord injury use iPSC-derived cells, not ntESCs Simple as that..
Conclusion
Human cloning, in the sense of producing a genetically identical born individual, remains a theoretical construct unsupported by current evidence. The molecular machinery that allows a somatic nucleus to direct the development of a whole organism functions imperfectly in primates, and the safety threshold for human application is effectively unattainable. Meanwhile, the term “cloning” in legitimate biomedical science has largely migrated toward molecular and cellular cloning—copying genes, editing sequences, and reprogramming cells—tools that illuminate biology and treat disease without invoking the specter of replicated human beings. The scientific community’s self-governance, reinforced by law and ethics, has thus far held a firm line: we clone genes and cells to heal patients; we do not clone people.
